In invasive tumors, we have determined that the loss of Gli2 and Gli3 in fibroblasts decreases myeloid-derived suppressor cells (MDSCs) and increases natural killer (NK) cells, which in turn antagonize tumor growth. The gene discussed is GLI2; the disease is neoplasm.